AngioLab (XKRX:251280) Net Change in Cash : ₩-282.5 Mil (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is AngioLab Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

AngioLab's Net Change in Cash for the six months ended in Dec. 2023 was ₩-282.5 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-282.5 Mil.

AngioLab Net Change in Cash Historical Data

The historical data trend for AngioLab's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Net Change in Cash Chart

AngioLab Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-375.41

57.00

2,470.10

-2,311.36

-282.53

AngioLab Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Net Change in Cash	Get a 7-Day Free Trial			-375.41	57.00	2,470.10	-2,311.36	-282.53

AngioLab Net Change in Cash Calculation

AngioLab's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-836.091	+	614.175	+	-60.628	+	0.018
	=	-282.5

AngioLab's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -836.091 + 614.175 + -60.628 + 0.018

= -282.5

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-282.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AngioLab Net Change in Cash Related Terms
Thank you for viewing the detailed overview of AngioLab's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioLab (XKRX:251280) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Net Change in Cash

Comparable Companies

XKRX:072520 XKRX:446440 XKRX:215380 XKRX:322970 XKRX:283100 XKRX:950220 XKRX:343090 XKRX:179530 XKRX:388610 XKRX:208340 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX

Traded in Other Exchanges

N/A

Address

65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN

Website

http://www.angiolab.co.kr

AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines